[tabs]
[tab title=”2020″]
1. Usefulness of day 7 lumefantrine plasma concentration as a predictor of malaria treatment outcome in under‑fives children treated with artemether-lumefantrinein Tanzania. Manase Kilonzi, Omary Minzi, Ritah Mutagonda, Vito Baraka, Philip Sasi, Eleni Aklillu, Appolinary Kamuhabwa. Malar J. 2020 Feb 11;19(1):66. doi: 10.1186/s12936-020-3150-y. [Read more>>]
2. Effectiveness and safety of intermittent preventive treatment for malaria using either dihydroartemisinin-piperaquine or artesunate-amodiaquine in reducing malaria related morbidities and improving cognitive ability in school-aged children in Tanzania: a study protocol for a controlled randomised trial. Geofrey Makenga, Vito Baraka, Filbert Francis, Swabra Nakato, Samwel Gesase, George Mtove, Rashid Madebe, Edna Kyaruzi, Daniel T. Minja, John P.A. Lusingu , Jean-Pierre Van, geertruyden. Contemp Clin Trials Commun. 2020 Feb 20;17:100546. doi: 10.1016/j.conctc.2020.100546. [Read more>>]
3. Cancer Mortality Patterns in Tanzania: A Retrospective Hospital-Based Study. Emanuel P. Lyimo, Susan F. Rumisha, Irene R. Mremi, Chacha D. Mangu, Coleman Kishamawe, Mercy G. Chiduo, Lucas E. Matemba, Veneranda M. Bwana, Isolide S. Massawe, Leonard E.G. Mboera. JCO Glob Oncol. 2020 Feb;6:224-232. doi: 10.1200/JGO.19.00270. [Read more>>]
4. In Vivo Imaging of the Buccal Mucosa Shows Loss of the Endothelial Glycocalyx and Perivascular Hemorrhages in Pediatric Plasmodium falciparum Malaria.Eric Lyimo, Lars Emil Haslund, Thomas Ramsing, Christian William Wang, Akinwale Michael Efunshile, Alphaxard Manjurano, Victor Makene, John Lusingu, Thor Grundtvig Theander, Jørgen Anders Lindholm Kurtzhals, Rasmus Paulsen, Casper Hempel. Infect Immun. 2020 Feb 20;88(3):e00679-19. doi: 10.1128/IAI.00679-19. [Read more>>]
5. Transmission of Cryptosporidium Species Among Human and Animal Local Contact Networks in Sub-Saharan Africa: A Multicounty Study. Ralf Krumkamp, Cassandra Aldrich, Oumou Maiga-Ascofare, Joyce Mbwana, Njari Rakotozandrindrainy, Steffen Borrmann, Simone M. Caccio, Raphael Rakotozandrindrainy, Ayola Akim Adegnika, John P. A. Lusingu, John Amuasi, Jürgen May, and CRYPTO Study Group. Clin Infect Dis. 2021 Apr 15; 72(8): 1358–1366. Published online 2020 Mar 9. doi: 10.1093/cid/ciaa223. [Read more>>]
6. Effect of sulfadoxine‑pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania. Wigilya P. Mikomangwa, Omary Minzi, Ritah Mutagonda, Vito Baraka, Eulambius M. Mlugu, Eleni Aklillu , Appolinary A. R. Kamuhabwa. Malar J. 2020 Apr 19;19(1):160. doi: 10.1186/s12936-020-03234-4. [Read more>>]
7. Herpes Simplex virus type 2 seroprevalence and risk factors among adolescents and youth with HIV-1 in Northern, Tanzania. Rashid Madebe, Ireen Kiwelu, Arnold Ndaro, Filbert Francis, Vito Baraka, Zahra Theilgaard, Terese Katzenstein. J Infect Dev Ctries. 2020 Apr 30;14(4):398-403. doi: 10.3855/jidc.11599. [Read more>>]
8. Prevalence and Correlates of Lymphatic Filariasis Infection and Its Morbidity Following Mass Ivermectin and Albendazole Administration in Mkinga District, North-Eastern Tanzania. Adam M. Fimbo, Omary M.S. Minzi, Bruno P. Mmbando, Abbie Barry, Alex F. Nkayamba, Kissa W. Mwamwitwa, Alpha Malishee, Misago D. Seth, Williams H. Makunde, Parthasarathi Gurumurthy, John P.A. Lusingu, Appolinary A.R. Kamuhabwa, Eleni Aklillu. J Clin Med. 2020 May 21;9(5):1550. doi: 10.3390/jcm9051550. [Read more>>]
9. PRKN-related familial Parkinson’s disease: First molecular confirmation from East Africa. M C J Dekker, J M Suleiman, D Bhwana, W P Howlett, S M Rashid, R van Minkelen, B C Hamel. Parkinsonism Relat Disord. 2020 Apr;73:14-15. doi: 10.1016/j.parkreldis.2020.02.014. [Read more>>]
10. Impact of zinc oxide nanoparticles in aqueous environments: influence of concentrations, natural organic matter and ionic strength. Deogratius T. Maiga, Hlengilizwe Nyoni, Thabo T. Nkambule, Bhekie B. Mamba, Titus Alfred Makudali Msagati. Inorganic and Nano-Metal Chemistry. doi: 10.1080/24701556.2020.1724145. [Read more>>]
[/tab]
[tab title=”2019″]
1. Application of community-based and integrated strategy to reduce malaria disease burden in southern Tanzania: the study protocol of China-UK-Tanzania pilot project on malaria control. Duoquan Wang, Prosper Chaki, Yeromin Mlacha, Tegemeo Gavana, Mihayo Gabriel Michael, Rashid Khatibu, Jun Feng, Zheng-Bin Zhou, Kang-Ming Lin, Shang Xia, He Yan, Deus Ishengoma, Susan Rumisha, Sigbert Mkude, Renata Mandike, Frank Chacky, Charles Dismasi, Salim Abdulla, Honorati Masanja, Ning Xiao and Xiao-Nong Zhou. Infect Dis Poverty. 2019 Jan 8;8(1):4. doi: 10.1186/s40249-018-0507-3. [Read more>>]
[/tab]
[tab title=”2018″]
1. High efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Muheza and Kigoma Districts, Tanzania. Mandara CI, Kavishe RA, Gesase S, Mghamba J, Ngadaya E, Mmbuji P, Mkude S, Mandike R, Njau R, Mohamed A, Lemnge MM, Warsame M, Ishengoma DS. Malar J. 2018 Jul 11;17(1):261. doi: 10.1186/s12936-018-2409-z. [Read more>>]
[/tab]
[tab title=”2017″]
1. Trends of Plasmodium falciparum prevalence in two communities of Muheza district North-eastern Tanzania: correlation between parasite prevalence, malaria interventions and rainfall in the context of re-emergence of malaria after two decades of progressively declining transmission. Ishengoma DS, Mmbando BP, Mandara CI, Chiduo MG, Francis F, Timiza W, Msemo H, Kijazi A, Lemnge MM, Malecela MN, Snow RW, Alifrangis M, Bygbjerg IC.Malar J. 2018 Jul 6;17(1):252. doi: 10.1186/s12936-018-2395-1. [Read more>>]
[/tab]
[tab title=”2016″]
1. Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial. Mwaiswelo R, Ngasala B, Jovel I, Aydin-Schmidt B, Gosling R, Premji Z, Mmbando B, Björkman A, Mårtensson A.Malar J. 2016 Aug 26;15(1):435. doi: 10.1186/s12936-016-1430-3.[Read more>>]
2. Safety of a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen for treatment of acute uncomplicated Plasmodium falciparum malaria in Tanzania. Mwaiswelo R, Ngasala BE, Jovel I, Gosling R, Premji Z, Poirot E, Mmbando BP, Björkman A, Mårtensson A.Malar J. 2016 Jun 10;15:316. doi: 10.1186/s12936-016-1341-3.[Read more>>]
3. Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data. WWARN Gametocyte Study Group.BMC Med. 2016 May 24;14:79. doi: 10.1186/s12916-016-0621-7.[Read more>>]
4. Four Artemisinin-Based Treatments in African Pregnant Women with Malaria. PREGACT Study Group, Pekyi D, Ampromfi AA, Tinto H, Traoré-Coulibaly M, Tahita MC, Valéa I, Mwapasa V, Kalilani-Phiri L, Kalanda G, Madanitsa M, Ravinetto R, Mutabingwa T, Gbekor P, Tagbor H, Antwi G, Menten J, De Crop M, Claeys Y, Schurmans C, Van Overmeir C, Thriemer K, Van Geertruyden JP, D’Alessandro U, Nambozi M, Mulenga M, Hachizovu S, Kabuya JB, Mulenga J.N Engl J Med. 2016 Mar 10;374(10):913-27. doi: 10.1056/NEJMoa1508606.[Read more>>]
5. Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study. Rupérez M, González R, Mombo-Ngoma G, Kabanywanyi AM, Sevene E, Ouédraogo S, Kakolwa MA, Vala A, Accrombessi M, Briand V, Aponte JJ, Manego Zoleko R, Adegnika AA, Cot M, Kremsner PG, Massougbodji A, Abdulla S, Ramharter M, Macete E, Menéndez C.PLoS Med. 2016 Feb 23;13(2):e1001964. doi: 10.1371/journal.pmed.1001964. eCollection 2016 Feb.[Read more>>]
6. A deep sequencing tool for partitioning clearance rates following antimalarial treatment in polyclonal infections. Mideo N, Bailey JA, Hathaway NJ, Ngasala B, Saunders DL, Lon C, Kharabora O, Jamnik A, Balasubramanian S, Björkman A, Mårtensson A, Meshnick SR, Read AF, Juliano JJ.Evol Med Public Health. 2016 Jan 27;2016(1):21-36. doi: 10.1093/emph/eov036.[Read more>>]
7. Treatment outcomes in a safety observational study of dihydroartemisinin/piperaquine (Eurartesim(®)) in the treatment of uncomplicated malaria at public health facilities in four African countries. Adjei A, Narh-Bana S, Amu A, Kukula V, Nagai RA, Owusu-Agyei S, Oduro A, Macete E, Abdulla S, Halidou T, Sie A, Osei I, Sevene E, Asante KP, Mulokozi A, Compaore G, Valea I, Adjuik M, Baiden R, Ogutu B, Binka F, Gyapong M.Malar J. 2016 Jan 27;15:43. doi: 10.1186/s12936-016-1099-7.[Read more>>]
[/tab]
[/tabs]